2770247-90-8
2770247-90-8
Chemical Structure
HSD17B13-IN-80-d2
- CAS No.: 2770247-90-8
- Formula:C25H16D2Cl2F3N3O3
- Molecular Weight:538.34
InChIKey: VWLKLPGOFPETDX-ZWGOZCLVSA-N
SMILES: OC1=C(Cl)C=C(C(NC2=C3C(N=C(C)N(C(C4=CC=CC=C4C(F)(F)F)([2H])[2H])C3=O)=C(C)C=C2)=O)C=C1Cl
Biological Activity: HSD17B13-IN-80-d2 (Compound 200) is the the deuterium labeled HSD17B13-IN-80 (HY-163263). HSD17B13-IN-80 is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of ≤ 0.1 μM for estradiol. HSD17B13-IN-80 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH, as well as drug-induced liver injury (DILI)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HSD17B13-IN-80-d2 | HSD17B13-IN-80-d2 (Compound 200) is the the deuterium labeled HSD17B13-IN-80 (HY-163263). HSD17B13-IN-80 is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of ≤ 0.1 μM for estradiol. HSD17B13-IN-80 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH, as well as drug-induced liver injury (DILI). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HSD17B13-IN-80-dsub>3 | HSD17B13-IN-80-d3 (179) is a 17β-Hydroxysteroid dehydrogenases (HSD17B13) inhibitor, with an IC50 of <0.1 μM for Estradiol. Used in NAFLD (Nonalcoholic fatty liver diseases) research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HSD17B13-IN-80 | HSD17B13-IN-80 (Compound 151) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of ≤ 0.1 μM for estradiol. HSD17B13-IN-80 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH, as well as drug-induced liver injury (DILI). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
